Large Molecule Bioanalysis done differently

To help you achieve more.

We are a bioanalytical lab that has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

biomarkers

Biomarkers

immunogenicity

Immunogenicity

pharmacokinetics

Pharmacokinetics (PK)

cell-based-assays

Cell-Based Assays

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

biosimilars

Biosimilars

gene-therapy

Gene Therapy

antibody-drug-conjugates

Antibody Drug Conjugates (ADCs)

immuno-oncology

Immuno-oncology

platform comparison guide

Biacore Webinar 2019
ON-DEMAND WEBINAR

“Principles of Immunogenicity Assessment Using Biacore™ T200 SPR System”

Co-Hosted with GE Healthcare

The assessment of unwanted immunogenicity is a key parameter in the development process of biological protein drugs. In this webinar, BioAgilytix’s experts Dr. Arno Kromminga and Dr. Daniel Worms discuss aspects of when and how to use the Biacore™ T200 SPR System to obtain a deeper understanding of unwanted immunogenicity.

Access Now

The Bioagilytix Perspective

Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

resource center

Visit Resource Center

usa europe labs

Advanced bioanalytical lab facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • 2 Days Agoview on linkedin

    BioAgilytix

    The wait is over: Critical Path Institute (C-Path) has released its Points to Consider document providing a comprehensive user guide for bioanalytical assay validation in support of clinical biomarker qualification in biological fluids. Our own Dr. Afshin Safavi contributed to this paper and we are thrilled to see consensus being established around best practice approaches for the development and qualification of clinical biomarkers, including considerations for sample collection, bioanalytical parameters to assess during assay validation, and the setting up of proper acceptance criteria. Access the full document here: https://lnkd.in/et4mMNq

  • 2 Days Agoview on linkedin

    BioAgilytix

    “New aspects in regulated Bioanalysis” Workshop: Join PD Dr. Arno Kromminga & Dr. Lydia Michaut on 28 June in Munich, Germany as they cover new aspects in the understanding of immunogenicity including novel advanced medical therapies such as gene therapies. View the full workshop agenda here: https://bit.ly/2RilmZz and contact Soubhik Banerjee at soubhik.banerjee@bioagilytix.de to reserve your spot.

  • 3 Days Agoview on linkedin

    BioAgilytix

    Our team is seeking a Director (GMP) to provide strategic and managerial oversight of #GMP bioanalytical operations at our U.S. headquarters in Durham, North Carolina. View the qualifications and apply today: https://lnkd.in/e_P72jB

global map

Advancing Bioanalytical Excellence Internationally

Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.